First Over-the-Counter Continuous Glucose Monitor Launches for Diabetes Management

Monday, 26 August 2024, 06:03

Continuous Glucose Monitor launches today with the introduction of Dexcom's Stelo, the first over-the-counter device for diabetes management without prescriptions. This innovative technology caters to individuals older than 18 years who either have diabetes or prediabetes but are not currently on insulin or at risk for hypoglycemia, making glucose monitoring more accessible and convenient.
Medscape
First Over-the-Counter Continuous Glucose Monitor Launches for Diabetes Management

Continuous Glucose Monitoring Revolutionized

The realm of diabetes management has just witnessed a significant shift with the launch of Dexcom's Stelo. This device marks the first time a continuous glucose monitor (CGM) is offered over-the-counter, heralding a new era for those needing easier access to their glucose levels.

Who Can Benefit?

Designed explicitly for individuals aged 18 and over, this over-the-counter CGM is ideal for those diagnosed with diabetes or prediabetes who are not insulin-dependent and do not face hypoglycemia risks.

  • Accessibility: No prescriptions are required.
  • Convenience: Easy monitoring of glucose levels.
  • Health Insights: Empowering users with real-time data.

With Stelo, Dexcom pushes the boundaries of health technology to promote better self-management of diabetes


This article was prepared using information from open sources in accordance with the principles of Ethical Policy. The editorial team is not responsible for absolute accuracy, as it relies on data from the sources referenced.


Related posts


Newsletter

Subscribe to our newsletter for the most reliable and up-to-date tech news. Stay informed and elevate your tech expertise effortlessly.

Subscribe